| Literature DB >> 33815867 |
Pietro Gentile1,2.
Abstract
In this second return of the pandemic, January 2021, it appears to be clear that a Nano-sized organism, the SARS-CoV-2, has rendered the human race helpless, made the global health status decline, and drowned the world economy. However, it does not appear clear the real origin of the SARS-CoV-2 and the aim of this work is to report and discuss, maybe for the first time since the pandemic began, the scientific data published in this specific field, analyzing the potentially available weapons against the SARS-CoV-2. About this last point, a ray of hope comes from the potential of Mesenchymal Stem Cells (MSCs) that has already been established in Coronavirus Disease 2019 (COVID-19), and in particular from the Adipose-Derived Mesenchymal Stem Cells (AD-MSCs). However, cell-based therapy has its own limits, especially represented by the know-how in this field and by the rules of applications. It was suggested a biological therapy using AD-MSCs as a weapon against COVID-19, as they can be a game-changer owing to their immuno-modulatory nature, which combats the cytokine storm characterizing this disease, and their practical efficiency, which will realistically aid large access to therapy worldwide. copyright:Entities:
Keywords: SARS-CoV-2 adipose-derived stem cells; SARS-CoV-2 origin; adipose-derived stem cells coronavirus; regenerative plastic surgery; stem cell therapy COVID-19
Year: 2021 PMID: 33815867 PMCID: PMC7990360 DOI: 10.14336/AD.2021.0121
Source DB: PubMed Journal: Aging Dis ISSN: 2152-5250 Impact factor: 6.745